HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide...

Details HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide... HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide...

2011-05-03

2011-05-03

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S321000

Reexamination Certificate

active

07935711

ABSTRACT:
HIV replication inhibitors of formula (I) a pharmaceutically acceptable addition salt; or a stereochemically isomeric form thereof, wherein R1is halo; R2and R3each independently are C1-6alkyl. Pharmaceutical compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.

REFERENCES:
patent: 2008/0214588 (2008-09-01), De Kock et al.
patent: 2008/0262007 (2008-10-01), Guillemont et al.
patent: 2009/0124644 (2009-05-01), Heeres et al.
patent: 2009/0181993 (2009-07-01), Guillemont et al.
patent: 2010/0016317 (2010-01-01), Guillemont et al.
patent: 2010/0121060 (2010-05-01), De Kock et al.
patent: 2010/0168104 (2010-07-01), Guillemont et al.
patent: 2010/0234375 (2010-09-01), Guillemont et al.
patent: WO 00/27825 (2000-05-01), None
patent: WO 2004/002410 (2004-01-01), None
International Search Report dated Jun. 22, 2006 for related International Application No. PCT/EP2006/060115.

Affiliated with

Also associated with

Rating

HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2676194